These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24502567)
21. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020 [No Abstract] [Full Text] [Related]
22. Opioids confer myocardial tolerance to ischemia: interaction of delta opioid agonists and antagonists. Bolling SF; Badhwar V; Schwartz CF; Oeltgen PR; Kilgore K; Su TP J Thorac Cardiovasc Surg; 2001 Sep; 122(3):476-81. PubMed ID: 11547297 [TBL] [Abstract][Full Text] [Related]
23. Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery. Ansley DM; Raedschelders K; Chen DD; Choi PT Contemp Clin Trials; 2009 Jul; 30(4):380-5. PubMed ID: 19336262 [TBL] [Abstract][Full Text] [Related]
26. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting. Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192 [TBL] [Abstract][Full Text] [Related]
27. Delayed cardioprotection is mediated via a non-peptide delta opioid agonist, SNC-121, independent of opioid receptor stimulation. Patel HH; Hsu A; Gross GJ Basic Res Cardiol; 2004 Jan; 99(1):38-45. PubMed ID: 14685704 [TBL] [Abstract][Full Text] [Related]
28. Cardioprotection by volatile anesthetics: established scientific principle or lingering clinical uncertainty? Pagel PS J Cardiothorac Vasc Anesth; 2009 Oct; 23(5):589-93. PubMed ID: 19789055 [No Abstract] [Full Text] [Related]
29. Organ protection by volatile anesthetics in non-coronary artery bypass grafting surgery. Landoni G; Turi S; Bignami E; Zangrillo A Future Cardiol; 2009 Nov; 5(6):589-603. PubMed ID: 19886786 [TBL] [Abstract][Full Text] [Related]
30. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger. Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577 [TBL] [Abstract][Full Text] [Related]
31. Adenosine transport blockade restores attenuated cardioprotective effects of adenosine preconditioning in the isolated diabetic rat heart: potential crosstalk with opioid receptors. Sharma NK; Mahadevan N; Balakumar P Cardiovasc Toxicol; 2013 Mar; 13(1):22-32. PubMed ID: 22948709 [TBL] [Abstract][Full Text] [Related]
33. Pain treatment with opioids : achieving the minimal effective and the minimal interacting dose. Geppetti P; Benemei S Clin Drug Investig; 2009; 29 Suppl 1():3-16. PubMed ID: 19445550 [TBL] [Abstract][Full Text] [Related]
34. Non-analgesic effects of opioids: cardiovascular effects of opioids and their receptor systems. Headrick JP; Pepe S; Peart JN Curr Pharm Des; 2012; 18(37):6090-100. PubMed ID: 22747541 [TBL] [Abstract][Full Text] [Related]
35. TRPV1 and TRPV4 channels: potential therapeutic targets for ischemic conditioning-induced cardioprotection. Randhawa PK; Jaggi AS Eur J Pharmacol; 2015 Jan; 746():180-5. PubMed ID: 25449039 [TBL] [Abstract][Full Text] [Related]
36. The effects of volatile anesthetics on cardiac ischemic complications and mortality in CABG: a meta-analysis. Yu CH; Beattie WS Can J Anaesth; 2006 Sep; 53(9):906-18. PubMed ID: 16960269 [TBL] [Abstract][Full Text] [Related]
37. Morphine reduces the threshold of remote ischemic preconditioning against myocardial ischemia and reperfusion injury in rats: the role of opioid receptors. Lu Y; Dong CS; Yu JM; Li H J Cardiothorac Vasc Anesth; 2012 Jun; 26(3):403-6. PubMed ID: 21982329 [TBL] [Abstract][Full Text] [Related]
38. [Opioids--triggers of adaptive phenomenon of ischemic preconditioning of heart]. Maslov LN; Naryzhnaia NV; Podoksenov IuK; Mrochek AG; Gorbunov AS; Tsibul'nikov SIu Ross Fiziol Zh Im I M Sechenova; 2014 Sep; 100(9):993-1007. PubMed ID: 25697009 [TBL] [Abstract][Full Text] [Related]
39. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study. Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858 [TBL] [Abstract][Full Text] [Related]